Susquehanna Fundamental Investments LLC Takes Position in Trupanion, Inc. $TRUP

Susquehanna Fundamental Investments LLC purchased a new position in Trupanion, Inc. (NASDAQ:TRUP) in the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 67,780 shares of the financial services provider’s stock, valued at approximately $1,679,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Royal Bank of Canada boosted its position in Trupanion by 60.6% during the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock valued at $1,109,000 after purchasing an additional 11,233 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Trupanion by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock valued at $731,000 after purchasing an additional 858 shares during the last quarter. Millennium Management LLC raised its holdings in Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock worth $9,987,000 after purchasing an additional 113,490 shares in the last quarter. Invesco Ltd. raised its holdings in Trupanion by 35.1% in the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after purchasing an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC purchased a new stake in shares of Trupanion during the second quarter valued at about $249,000.

Trupanion Trading Down 4.4%

Trupanion stock opened at $27.88 on Wednesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market cap of $1.22 billion, a PE ratio of 52.60, a price-to-earnings-growth ratio of 1.97 and a beta of 1.45. The stock has a 50-day moving average of $27.21 and a two-hundred day moving average of $25.89. Trupanion, Inc. has a one year low of $21.16 and a one year high of $46.98.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. During the same quarter in the previous year, the firm earned $0.22 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. On average, research analysts anticipate that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.

Insider Activity at Trupanion

In related news, CEO Margaret Tooth sold 978 shares of Trupanion stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the sale, the chief executive officer directly owned 175,401 shares in the company, valued at $5,095,399.05. This trade represents a 0.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the sale, the executive vice president directly owned 78,062 shares in the company, valued at approximately $1,717,364. This represents a 7.88% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 18,720 shares of company stock valued at $503,038 over the last 90 days. Company insiders own 5.58% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on TRUP. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 24th. Stifel Nicolaus raised their target price on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Thursday, August 20th. Weiss Ratings raised shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, August 26th. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday, July 15th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $39.20.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.